Watch endpoint Clinical’s presentation “Innovative Trial Design during COVID-19” from the virtual session at Clinical Trials Europe 2020.
In this session, led by endpoint’s VP of Product Strategy, Cat Hall, you will learn:
- Trends in our Industry
- Impact of COVID-19 on Clinical Trials
- How the Tools we had were leveraged
- How the total Eco-system will continue to evolve
Catherine Hall, VP of Product Strategy, endpoint Clinical
Cat Hall started her career as an academic scientist in Molecular and Cellular Biology before finishing her MBA and transitioning into Pharmaceutical Supply Chain Management. During her career, she developed notable expertise not only in clinical supplies but also in training development, process improvement, managing partnerships, and the design and implementation of technologies such as Interactive Response Technology (IRT). She is well-known for focusing on bridging the GMP/GCP gap by bringing supply chain customer service through the last mile to patients. Cat joined endpoint in 2019 as VP of Product Strategy to help continue to bring the customer voice forward into shaping the future of IRT.